Kenvue Inc. (KVUE) Stock Price

KVUEStock

$19.33−10.09%52W

Market Cap$37.13B

P/E25.09x

PEG Ratio1.56

Div yield4.47%

Beta0.45

KVUE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-8.33%

Price vs S&P 500 (4W)-4.67%

PEG Ratio1.56

VGM Score52.72

P/E Ratio (Annual)25.09x

Indicated Dividend Yield (Annual)4.47%

P/CF (Annual)16.79x

Book Value / Share (Quarterly)$5.50

P/TBV (Annual)15.90x

Indicated Dividend (Annual)$0.84

Revenue Growth (3Y)0.39%

Cash Flow / Share (Quarterly)$1.00

Payout Ratio (TTM)96.02%

Price vs S&P 500 (YTD)0.68%

Gross Margin (TTM)58.64%

Net Profit Margin (TTM)10.76%

EPS (TTM)$0.86

10-Day Avg Trading Volume18.83M

EPS Excl Extra (TTM)$0.86

Revenue Growth (5Y)0.89%

EPS (Annual)$0.76

Dividend / Share (Annual)$0.83

ROI (Annual)7.62%

Gross Margin (Annual)58.62%

Net Profit Margin (5Y Avg)10.92%

Cash / Share (Quarterly)$0.58

P/E Basic Excl Extra (TTM)22.24x

Revenue Growth QoQ (YoY)3.02%

P/E Normalized (Annual)25.09x

ROA (Last FY)5.43%

Revenue Growth TTM (YoY)1.76%

EBITD / Share (TTM)$1.66

ROE (5Y Avg)11.91%

Operating Margin (TTM)17.07%

Cash Flow / Share (Annual)$0.90

P/B Ratio3.49x

P/B Ratio (Quarterly)3.47x

Net Income / Employee (Annual)$67,500

EV / Revenue (TTM)2.87x

Net Interest Coverage (TTM)5.70x

ROA (TTM)6.15%

EPS Growth QoQ (YoY)8.86%

EV / EBITDA (TTM)13.84x

EPS Incl Extra (Annual)$0.76

Current Ratio (Annual)0.96x

Quick Ratio (Quarterly)0.64x

3-Month Avg Trading Volume20.23M

52-Week Price Return-10.09%

EV / Free Cash Flow (Annual)25.70x

P/E Incl Extra (TTM)22.24x

Revenue / Employee (TTM)$707,400

Tangible BV / Share (Quarterly)$1.12

P/S Ratio (Annual)2.44x

Asset Turnover (Annual)0.56x

52-Week High$21.78

Operating Margin (5Y Avg)16.32%

EPS Excl Extra (Annual)$0.76

CapEx CAGR (5Y)15.71%

26-Week Price Return2.91%

Quick Ratio (Annual)0.61x

13-Week Price Return11.28%

Total Debt / Equity (Annual)0.79x

Current Ratio (Quarterly)1.01x

Enterprise Value$44.25B

Revenue / Share Growth (5Y)0.52%

Asset Turnover (TTM)0.57x

Revenue / Employee (Annual)$694,400

Inventory Turnover (Annual)3.84x

Pretax Margin (Annual)13.22%

Cash / Share (Annual)$0.55

3-Month Return Std Dev23.86%

Gross Margin (5Y Avg)57.11%

Net Income / Employee (TTM)$76,100

ROE (Last FY)13.66%

Net Interest Coverage (Annual)6.33x

EPS Basic Excl Extra (Annual)$0.76

P/FCF (TTM)19.27x

Receivables Turnover (TTM)6.41x

EV / Free Cash Flow (TTM)23.12x

Total Debt / Equity (Quarterly)0.80x

EPS Incl Extra (TTM)$0.86

Receivables Turnover (Annual)6.65x

ROI (TTM)8.59%

P/S Ratio (TTM)2.39x

Pretax Margin (5Y Avg)14.73%

Revenue / Share (Annual)$7.86

Tangible BV / Share (Annual)$1.08

Forward P/E15.77x

Free OCF CAGR (5Y)-11.48%

Price vs S&P 500 (52W)-28.40%

P/E Ratio (TTM)22.24x

EPS Growth TTM (YoY)17.17%

Year-to-Date Return12.64%

5-Day Price Return3.35%

EPS Normalized (Annual)$0.76

ROA (5Y Avg)6.07%

Net Profit Margin (Annual)9.72%

Month-to-Date Return0.99%

EBITD / Share (Annual)$1.54

EPS Growth (3Y)-11.57%

Operating Margin (Annual)15.96%

LT Debt / Equity (Annual)0.64x

P/CF (TTM)15.86x

ROI (5Y Avg)8.43%

P/E Excl Extra (TTM)22.24x

LT Debt / Equity (Quarterly)0.67x

EPS Basic Excl Extra (TTM)$0.86

P/TBV (Quarterly)17.05x

Payout Ratio (Annual)107.55%

P/B Ratio (Annual)3.06x

Dividend / Share (TTM)$0.83

Inventory Turnover (TTM)3.64x

Pretax Margin (TTM)14.43%

Book Value / Share (Annual)$5.62

Price vs S&P 500 (13W)8.49%

Dividend Yield (TTM)4.32%

Beta0.45x

P/FCF (Annual)21.42x

Revenue / Share (TTM)$8.01

ROE (TTM)15.58%

52-Week Low$14.02

vGradeC

gGradeC

mGradeC

vgmGradeC

KVUE Earnings Surprise History

Q2 250.29est. 0.28

Q3 250.28est. 0.26

Q4 250.27est. 0.22

Q1 260.32est. 0.26

Q2 260.31est. 0.32

KVUE Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.75

2.72

3.40

Industry Peers — Cosmetics & Toiletries(22)

Symbol	Value Score	Growth Score	Momentum Score	Price
KVUEKenvue Inc.	C	C	C	$19.33
CLColgate-Palmolive Company	C	C	C	$91.33
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	C	$10.18
ELThe Estee Lauder Companies Inc. Class A	C	D	B	$104.85
ELFe.l.f. Beauty, Inc.	C	B	B	$105.77
IPARInterparfums, Inc. Common Stock	C	B	B	$116.56
COTYCOTY INC	B	C	B	$2.67
EPCEdgewell Personal Care Company	B	D	B	$28.95
ODDODDITY Tech Ltd. Class A Ordinary Shares	B	B	C	$14.20
YSGYatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares	A	C	C	$2.96
PTNMPitanium Limited Class A Ordinary shares	—	—	C	$10.39
WALDWaldencast plc Class A Ordinary Share	B	D	D	$1.36
SLSNSolesence, Inc. Common Stock	D	C	D	$0.94
AXILAXIL Brands, Inc.	C	C	D	$6.25
UGUnited-Guardian, Inc.	B	D	C	$7.27
CABRCaring Brands, Inc. Common Stock	—	—	D	$1.28
BIOTInstinct Bio Technical Company Holdings Inc. Ordinary Shares	—	C	B	$0.44
BNKKBonk, Inc. Common Stock	A	A	D	$1.21
YCBDcbdMD, Inc. Common Stock	B	C	D	$0.52
BIOTWInstinct Bio Technical Company Holdings Inc. Warrants	—	—	A	$0.02
EMPGEmpro Group Inc. Ordinary shares	—	—	A	$0.00
OLPXOlaplex Holdings, Inc. Common Stock	C	D	C	$0.00
WALDWWaldencast plc Warrant	—	—	D	$0.03

About Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company with over $15 billion in annual revenue, offering products across pain management, oral care, cough and cold care, and skincare through iconic brands including Tylenol, Listerine, Aveeno, and Neutrogena. Spun off from Johnson & Johnson in May 2023, the company agreed to be acquired by Kimberly-Clark in November 2025, with the transaction expected to close in the second half of 2026.